Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2017

Mar 2, 2017

29995_dirs_2017-03-02_6146de10-dc7d-483b-9391-469a0c87cdbc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2017-02-28

Reporting Person: Townsend Christopher G (President, Asia)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-28 Common Stock M 2595 Acquired 2595 Direct
2017-02-28 Common Stock D 2595 $52.49 Disposed 0 Direct
2017-02-28 Common Stock M 2500 Acquired 2500 Direct
2017-02-28 Common Stock D 2500 $52.49 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-28 Restricted Units (Cash-Payable) $ M 2595 Disposed Common Stock (2595) Direct
2017-02-28 Restricted Units (Cash-Payable) $ M 2500 Disposed Common Stock (2500) Direct

Footnotes

F1: Each Restricted Unit is the contingent right to receive cash equal to the closing price of one share of MetLife, Inc. common stock on the vesting date.

F2: The Restricted Units vest in three equal installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification on February 28, 2017 that MetLife, Inc. met specified financial goals.

F3: The Restricted Units vested in three equal installments on February 25, 2015, 2016 and 2017. This installment became payable following the certification on February 28, 2017 that MetLife, Inc. met specified financial goals.